Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announces it has received approval of its divestment plan for GRAIL from the European Commission (EC). While this does not mean the method of divestment has been finalized, the company is pleased to reach an agreement with the EC on specific divestment options as it represents an important milestone in the process.
Read the full article: Illumina’s Planned Divestment of GRAIL Approved by the European Commission //
Source: https://www.prnewswire.com/news-releases/illuminas-planned-divestment-of-grail-approved-by-the-european-commission-302115335.html